UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 25, 2009 (September 22, 2009)
HEALTHSPRING, INC.
(Exact name of registrant as specified in charter)
| |
|
|
|
|
| Delaware
|
|
001-32739
|
|
20-1821898 |
| (State or other jurisdiction of
|
|
(Commission
|
|
(IRS Employer |
| incorporation)
|
|
File Number)
|
|
Identification No.) |
| |
|
|
| 9009 Carothers Parkway |
|
|
| Suite 501 |
|
|
| Franklin, Tennessee
|
|
37067 |
| (Address of principal executive offices)
|
|
(Zip Code) |
(615) 291-7000
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment
of Certain Officers; Compensatory Arrangements of Certain Officers.
On September 22, 2009, Gerald V. Coil, the Executive Vice President and Chief Innovation
Officer of HealthSpring, Inc., a Delaware corporation (the “Company”), informed the Company’s Board
of Directors that he would resign all positions with the Company effective December 31, 2009. Mr.
Coil has served as the Company’s Executive Vice President and Chief Innovation Officer since March
19, 2009. From December 2006 to March 2009, Mr. Coil served as the Company’s Chief Operating
Officer.